Th?m khám ph? khoa ??nh k? 3 ??n six tháng m?t l?n ?? s?m phát hi?n v?n ?? b?t th??ng và h? tr? ?i?u tr? k?p th?i.mutations also (LoE 2b/B/In the past+/?). Though EMA acceptance has long been based upon studies of germline mutation carriers only, in picked cases dedication of BRCA standing from tumor tissue is feasible To guage the potential se